CHAI 2021 HIV market report: the state of the HIV market in low- and middle-income countries

Clinton Health Access Initiative (CHAI)

On 12 October 2021, CHAI release the 12th issue of their annual HIV market report.

The report reviews a global perspective on the complex, changing markets for HIV medicines in low- and middle-income countries.

All aspects of the global HIV response have had important updates over the past year.

These include:

  • The rollout of a generic, affordable paediatric formulation of dolutegravir.
  • Exciting clinical trial results set to change how cryptococcal meningitis is treated.
  • Further advances in long-acting drugs for HIV prevention.
  • Pricing deals that continue to make HIV self-testing more affordable.


An excellent 60-minute webinar review of the many changes to global HIV health is also available online:


CHAI. 2021 HIV market report (12th edition).

Links to other websites are current at date of posting but not maintained.